Tag: #Global Trends

AstraZeneca has reached a definitive agreement to acquire the remaining 50% stake in the Chinese development and commercialization rights for... Read more

Johnson & Johnson’s Janssen Biotech unit has signed a multi-target research collaboration with Isomorphic Labs, an Alphabet-backed startup at the... Read more

Synbio International has partnered with CRO Services Pty – a subsidiary of Resonance Health – to conduct a clinical trial... Read more

Genentech, a member of the Roche Group, has announced a significant expansion of its initial investment in a new manufacturing... Read more

Tesaro, an oncology-focused subsidiary of GSK, has entered into a global licensing agreement with South Korea’s Alteogen to develop a... Read more

Global contract research organization (CRO) Worldwide Clinical Trials has entered into a definitive agreement to acquire Catalyst Clinical Research. The... Read more

In a significant corporate reshuffle, Japanese pharmaceutical firm Shionogi & Co. has committed an additional $2.13 billion to increase its... Read more

In its first major M&A move under new CEO Luke Miels, GSK has reached a definitive agreement to acquire California-based... Read more

U.S. pharmaceutical giant Pfizer has agreed to divest its entire interest in ViiV Healthcare, a global specialist in HIV treatment,... Read more